Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Suppressed blood viral load doesn't mean the brain is clear too. A new study found that 1 in 5 HIV-positive adolescents with undetectable blood viral loads still showed HIV immune activity in their spinal fluid. The finding, from the landmark CHER trial, raises important questions for HIV cure research and treatment interruption studies.
When HIV is undetectable in the blood, doctors typically consider treatment a success — but a new study suggests the central nervous system (CNS) may tell a different story. Data from the Children with HIV Early Antiretroviral Therapy (CHER) trial, presented at the International AIDS Conference, found that HIV-related immune activity can persist in the spinal fluid of adolescents even when their blood viral loads are fully suppressed.
The study followed 79 adolescents who acquired HIV at birth and started antiretroviral therapy (ART) as infants. Among the 59 who had achieved viral suppression in their blood, 11 (about 1 in 5) still showed detectable HIV-specific immune responses in their cerebrospinal fluid. Researchers also noted that those with CNS immune activity tended to have had longer treatment interruptions and shorter total ART duration.
Importantly, researchers stress this does not mean ART is failing — it remains highly effective. Rather, the findings highlight a knowledge gap: the CNS may harbor its own distinct immunological environment that blood tests can't fully capture.
Key Takeaways:
Why it matters: As HIV cure research advances, understanding what happens beyond the bloodstream — especially in the brain — will be critical to developing truly durable remission strategies.
